These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 18161990)

  • 1. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
    Jung JH; Pendergast AM; Zipfel PA; Traugh JA
    Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
    Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
    Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of B cell adaptor for PI3-kinase (BCAP) as an Abl interactor 1-regulated substrate of Abl kinases.
    Maruoka M; Suzuki J; Kawata S; Yoshida K; Hirao N; Sato S; Goff SP; Takeya T; Tani K; Shishido T
    FEBS Lett; 2005 Jun; 579(14):2986-90. PubMed ID: 15893754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intramolecular SH3-domain interaction regulates c-Abl activity.
    Barilá D; Superti-Furga G
    Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
    Juang JL; Hoffmann FM
    Oncogene; 1999 Sep; 18(37):5138-47. PubMed ID: 10498863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
    Van Etten RA; Debnath J; Zhou H; Casasnovas JM
    Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proapoptotic function of the nuclear Crk II adaptor protein.
    Kar B; Reichman CT; Singh S; O'Connor JP; Birge RB
    Biochemistry; 2007 Sep; 46(38):10828-40. PubMed ID: 17764157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells.
    Ogawa S; Toyoshima H; Kozutsumi H; Hagiwara K; Sakai R; Tanaka T; Hirano N; Mano H; Yazaki Y; Hirai H
    Oncogene; 1994 Jun; 9(6):1669-78. PubMed ID: 8183562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficient method for protein phosphorylation using the artificially introduced of cognate-binding modules into kinases and substrates.
    Kobashigawa Y; Naito M; Inagaki F
    J Biotechnol; 2007 Sep; 131(4):458-65. PubMed ID: 17875337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Abl-binding protein interacts with p21-activated kinase 2 (PAK-2) to regulate PDGF-induced membrane ruffles.
    Machuy N; Campa F; Thieck O; Rudel T
    J Mol Biol; 2007 Jul; 370(4):620-32. PubMed ID: 17543336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic c-Abl provides a molecular 'Rheostat' controlling carcinoma cell survival and invasion.
    Kain KH; Gooch S; Klemke RL
    Oncogene; 2003 Sep; 22(38):6071-80. PubMed ID: 12955086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NESH (Abi-3) is present in the Abi/WAVE complex but does not promote c-Abl-mediated phosphorylation.
    Hirao N; Sato S; Gotoh T; Maruoka M; Suzuki J; Matsuda S; Shishido T; Tani K
    FEBS Lett; 2006 Nov; 580(27):6464-70. PubMed ID: 17101133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways.
    Voss J; Posern G; Hannemann JR; Wiedemann LM; Turhan AG; Poirel H; Bernard OA; Adermann K; Kardinal C; Feller SM
    Oncogene; 2000 Mar; 19(13):1684-90. PubMed ID: 10763825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional analysis of a new phosphorylation site (Y398) in the SH3 domain of Abi-1.
    Sato M; Maruoka M; Yokota N; Kuwano M; Matsui A; Inada M; Ogawa T; Ishida-Kitagawa N; Takeya T
    FEBS Lett; 2011 Mar; 585(6):834-40. PubMed ID: 21320496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfolded.
    Buffa P; Manzella L; Consoli ML; Messina A; Vigneri P
    Proteins; 2007 Apr; 67(1):1-11. PubMed ID: 17211892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
    Mysliwiec T; Perego R; Kruh GD
    Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
    Nagar B; Hantschel O; Seeliger M; Davies JM; Weis WI; Superti-Furga G; Kuriyan J
    Mol Cell; 2006 Mar; 21(6):787-98. PubMed ID: 16543148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of human c-Abl tyrosine kinase activity and regulation in S. pombe.
    Walkenhorst J; Goga A; Witte ON; Superti-Furga G
    Oncogene; 1996 Apr; 12(7):1513-20. PubMed ID: 8622867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of c-Abl kinase-promoted phosphorylation of Rad51 by specific antibodies reveals that Y54 phosphorylation is dependent on that of Y315.
    Popova M; Shimizu H; Yamamoto K; Lebechec M; Takahashi M; Fleury F
    FEBS Lett; 2009 Jun; 583(12):1867-72. PubMed ID: 19427856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.